Mainstream

Plus Therapeutics GAAP EPS of -$1.19 misses by $0.97, revenue of $1.06M misses by $0.08M

Plus Therapeutics GAAP EPS of -$1.19 misses by $0.97, revenue of $1.06M misses by $0.08M

Post ContentpstvRead More

You might also be interested in reading Tornado Cash Dev Pertsev’s $1.2B Money Laundering Allegations Detailed Ahead of Dutch Trial.

June 2, 2025
In Mainstream